“vir-biotechnology” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
IgGenix Grabs $10M to Advance Antibody Treatments for Allergies 08/05/20 San Francisco
Nura Bio Debuts With $73M and Plan to Develop “Neuroprotective” Drugs 07/29/20 San Francisco
Adimab Spinout Adagio Raises $50M for Coronavirus Antibody R&D 07/16/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
GSK and Sanofi Team Up on COVID-19 Vaccine, Aim for Clinic This Year 04/14/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months 04/06/20 San Francisco
Vir Advances Antibodies Against COVID-19, CEO Leads BIO’s Coronavirus Outreach 04/02/20 National
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More 10/11/19 San Francisco
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline 12/06/18 Raleigh Durham
Otsuka Ramps Up Its Antibody Game with $430M Visterra Acquisition 07/11/18 Boston
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M 05/24/18 Raleigh Durham
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid 05/15/18 National
With $59M, Casma and Ex-Constellation CEO Take Aim at Cellular Trash 05/03/18 Boston
Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup 11/02/17 San Francisco
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Page 1 of 1